BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35757898)

  • 1. Roles of osteoclasts in alveolar bone remodeling.
    Omi M; Mishina Y
    Genesis; 2022 Sep; 60(8-9):e23490. PubMed ID: 35757898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives of residual ridge resorption: Pathological activation of oral barrier osteoclasts.
    Kondo T; Kanayama K; Egusa H; Nishimura I
    J Prosthodont Res; 2023 Jan; 67(1):12-22. PubMed ID: 35185111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of osteoclasts in oral homeostasis and jawbone diseases.
    Omi M; Mishina Y
    Oral Sci Int; 2020 Jan; 18(1):14-27. PubMed ID: 34220275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
    Bordukalo-Nikšić T; Kufner V; Vukičević S
    Front Immunol; 2022; 13():869422. PubMed ID: 35558080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice.
    Kim YG; Kim MO; Kim SH; Kim HJ; Pokhrel NK; Lee JH; Lee HJ; Kim JY; Lee Y
    J Periodontol; 2020 Jun; 91(6):809-818. PubMed ID: 31675438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of bone homeostasis by bone cells].
    Nakashima T
    Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the coupling of osteoclasts and resorption to bone formation.
    Durdan MM; Azaria RD; Weivoda MM
    Semin Cell Dev Biol; 2022 Mar; 123():4-13. PubMed ID: 34756783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of osteoclastic bone resorption on bone remodeling.].
    Jimi E
    Clin Calcium; 2017; 27(12):1689-1695. PubMed ID: 29179162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo.
    Ihn HJ; Kim YS; Lim S; Bae JS; Jung JC; Kim YH; Park JW; Wang Z; Koh JT; Bae YC; Baek MC; Park EK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasomes in Alveolar Bone Loss.
    Li Y; Ling J; Jiang Q
    Front Immunol; 2021; 12():691013. PubMed ID: 34177950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of mono- and multinucleated bone resorbing cells of the zebrafish Danio rerio and their contribution to skeletal development, remodeling, and growth.
    Witten PE; Hansen A; Hall BK
    J Morphol; 2001 Dec; 250(3):197-207. PubMed ID: 11746460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA Nron Inhibits Bone Resorption in Periodontitis.
    Li J; Jin F; Cai M; Lin T; Wang X; Sun Y
    J Dent Res; 2022 Feb; 101(2):187-195. PubMed ID: 34157883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclasts and Remodeling Based Bone Formation.
    Kylmaoja E; Nakamura M; Tuukkanen J
    Curr Stem Cell Res Ther; 2016; 11(8):626-633. PubMed ID: 26477623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein Gα
    Nakano S; Inoue K; Xu C; Deng Z; Syrovatkina V; Vitone G; Zhao L; Huang XY; Zhao B
    Sci Rep; 2019 Mar; 9(1):4236. PubMed ID: 30862896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The regulatory mechanisms of bone metabolism by semaphorin].
    Hayashi M; Nakashima T; Takayanagi H
    Clin Calcium; 2012 Nov; 22(11):1693-9. PubMed ID: 23103813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently.
    Jensen PR; Andersen TL; Pennypacker BL; Duong LT; Engelholm LH; Delaissé JM
    Biochem Biophys Res Commun; 2014 Jan; 443(2):694-9. PubMed ID: 24333871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
    Parfitt AM
    Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.